Anti-AgingPreclinical

Thymulin

Facteur Thymique Serique (FTS)

Overview

Thymulin is a nonapeptide hormone produced exclusively by thymic epithelial cells that plays a central role in T-lymphocyte maturation and immune function. It is the primary thymic hormone involved in converting immature T-cell precursors into functional immune cells and requires zinc as a cofactor for biological activity. Thymulin levels decline dramatically with age in parallel with thymic involution making it a significant target in immunosenescence and longevity research. It has been studied in clinical contexts for immune deficiency conditions and as a potential anti-inflammatory agent.

Compound Data

Thymulin structure

Molecular Formula

C33H54N12O15

Molecular Weight

858.90 g/mol

IUPAC Name

(2S)-4-amino-2-[[(2S)-2-[[2-[[2-[[(2S)-5-amino-2-[[2-[[(2S)-6-amino-2-[[(2S)-2-[[(2S)-5-oxopyrrolidine-2-carbonyl]amino]propanoyl]amino]hexanoyl]amino]-3-hydroxypropanoyl]amino]-5-oxopentanoyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoyl]amino]-4-oxobutanoic acid

PubChem CID

71300623

Where does Thymulin sit?

See how this peptide compares across all 70 peptides in our database.

Mechanism of Action

Thymulin acts on immature thymocytes to induce the expression of T-cell surface markers and promote their differentiation into functional CD4+ helper T-cells and CD8+ cytotoxic T-cells. It requires zinc chelation for receptor binding — zinc-free thymulin is biologically inactive. Beyond T-cell maturation thymulin modulates cytokine production reducing pro-inflammatory interleukins while supporting regulatory T-cell function. It has demonstrated analgesic and anti-inflammatory effects in animal models through modulation of central and peripheral pain pathways. As thymulin levels decline with age immune surveillance weakens and inflammatory dysregulation increases — restoration of thymulin activity is one mechanism proposed for immune rejuvenation in aging.

Dosage Information

Typical Dose

10-50 mcg daily

Frequency

Once daily or every other day

Administration

Subcutaneous injection

Notes

Must be used with adequate zinc status for activity — ensure zinc sufficiency before use. Limited clinical data in humans.

Potential Side Effects

Limited human safety dataInjection site reactions (uncommon)Mild immune activation symptoms in first week (rare)

Community Experiences

Share Your Experience

Sign in to track your experience history and vote on others.
Verifying...

No experiences shared yet. Be the first!

Quick Facts

Administration
Subcutaneous injection
Typical Dose
10-50 mcg daily
Frequency
Once daily or every other day
References
0 curated + 50 from PubMed
Evidence Score
28.2 / 100